Curaleaf urges Aurora shareholders to tender; touts 45% premium, $4.00 offer

Curaleaf Holdings, Inc.

Offer of 0.3463 Curaleaf shares + $0.75 cash per Aurora share implies $4.00 price, 45% premium to $2.76.
Combined company would span 17 countries, >$1.5B revenue, ~$350M adj. EBITDA, $40M+ annual synergies.
Aurora's 4-quarter revenue down 14%, adj. EBITDA down 78%, operating cash flow negative; Curaleaf shares up ~50% vs Aurora down ~34% in H1 2026.
Aurora raised >$400M via dilutive issuances, selling shares as low as $2.60 (35% discount to offer).
Tender deadline Dec 1, 2026; shareholder Q&A with CEO Boris Jordan on Sept 17, 2026.

Featured in Daily 8-K Digest

Selected #2 for 2026-09-15. Read digest

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.